<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Right-sided colon cancer distinguishes Women vs Men — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Right-sided colon cancer</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>Women vs Men</strong>
</div>
<div class="entity-id">MESH:D015179 &nbsp;&middot;&nbsp; UNKNOWN:sex_difference</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 170.37<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 35 citations: <strong>170.37</strong><br><span style="color:#888">8&times; extends (+57.42) &middot; 18&times; supports (+104.54) &middot; 2&times; contradicts (+1.20) &middot; 7&times; applies (+7.21)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1038/s41598-020-61851-0">10.1038/s41598-020-61851-0</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1122">MTBLS1122</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 35 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>18</span><span class="cite-subtotal">&middot; +104.54</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.29</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">asparagine synthetase (ASNS) — increases → asparagine</span><span class="cite-claim-weight">+15.85</span><a href="../claim/cbbe665fd9d7a715.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — is_biomarker_for → Right-sided colon cancer in women</span><span class="cite-claim-weight">+15.85</span><a href="../claim/16c02890060bd0fd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — correlates_with → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/c6bfb7fbe92da16b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Polyamines — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/6dc001440b4efbb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b5a28b52535da3b5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phenylalanine metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/e9fd48260d547a3d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Indole-3-acetic acid — is_biomarker_for → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/6511d3c11340ec71.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan — correlates_with → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/8524ac2670b1fc08.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">SNP in IDO1 gene — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3c532898e577f272.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — is_biomarker_for → colorectal adenocarcinoma</span><span class="cite-claim-weight">+10.00</span><a href="../claim/e0e672f7538caff6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">de novo lipogenesis — increases → colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/52f46dfa92385363.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — distinguishes → lymphovascular invasion status in colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/235bd2fc243a7d41.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — decreases → lymphovascular invasion in colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/5b8f3f1ed7054976.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — is_biomarker_for → lymphovascular invasion-negative colorectal cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/942179be032f2958.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">reactive oxygen species-associated metabolites — distinguishes → right-sided colon cancer liver metastasis vs left-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1edd9967807dffc0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">carnitines — increases → left-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/f12db685aedc6256.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">carnitines — is_biomarker_for → fatty acid oxidation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1a181517f8c54d12.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:11px"></span><span>2</span><span class="cite-subtotal">&middot; +1.20</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.80</span><a href="../claim/2b2ddbab069d3634.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">KPIC2 + XGBoost — distinguishes → left-sided colon cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/996ea3d2ff2fcc97.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:44px"></span><span>8</span><span class="cite-subtotal">&middot; +57.42</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">XCMS + XGBoost — distinguishes → left-sided colon cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6f830dd32f1d2c9a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — predicts → 5-year Overall Survival in female CRC patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/2f6b8b95246fd19c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Serine — distinguishes → 5-year Overall Survival by sex in Colorectal Cancer</span><span class="cite-claim-weight">+19.02</span><a href="../claim/4421b19a889d7968.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophospholipids — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/b50eeb9d6580aa37.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">DESI-MSI spectral profiles — distinguishes → colorectal adenocarcinoma</span><span class="cite-claim-weight">+12.00</span><a href="../claim/7fb33aa3d4f25910.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Right-sided colon cancer liver metastasis — predicts → inferior overall survival</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3c80a5d454697be1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PI3K-AKT signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/71c571a33f544ed1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Transforming Growth Factor Beta signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6da8ef0fd47f1ee0.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:39px"></span><span>7</span><span class="cite-subtotal">&middot; +7.21</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">KPIC2 + XGBoost — distinguishes → liquor types</span><span class="cite-claim-weight">+0.30</span><a href="../claim/0f5b5ba06d9215b4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">XCMS + XGBoost — distinguishes → liquor types</span><span class="cite-claim-weight">+0.30</span><a href="../claim/57c5d440bdeaac05.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Purine metabolism pathway — predicts → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/46632f0d7be0301c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Metabolomic pathway activity score — distinguishes → Colorectal Cancer Recurrence vs. Non-Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/91e61fee63c809b1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — increases → colorectal adenocarcinoma</span><span class="cite-claim-weight">+6.00</span><a href="../claim/cbb3f19d3e71e361.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.30</span><a href="../claim/d3c6aea5531a14bf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">MEK-ERK signaling — increases → right-sided colon cancer liver metastasis</span><span class="cite-claim-weight">+0.30</span><a href="../claim/ae985e39be27dde2.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>3c5526531a45d1b2</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:sex_difference">UNKNOWN:sex_difference</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
